Valerio Therapeutics S.A.
ALVIO.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €10 | €12 | €16 | €25 |
| - Cash | €3 | €1 | €4 | €7 |
| + Debt | €19 | €13 | €13 | €9 |
| Enterprise Value | €26 | €24 | €26 | €28 |
| Revenue | €0 | €2 | €0 | €2 |
| % Growth | -92.6% | 1,814.6% | -95.1% | – |
| Gross Profit | -€2 | -€3 | -€0 | €1 |
| % Margin | -1,482.5% | -168.8% | -83.1% | 82.6% |
| EBITDA | -€0 | -€3 | -€9 | -€7 |
| % Margin | -82.5% | -173.9% | -10,592.1% | -403.4% |
| Net Income | -€0 | -€13 | -€11 | -€9 |
| % Margin | -165.1% | -761.3% | -12,312.4% | -483.3% |
| EPS Diluted | -0.001 | -0.084 | -0.067 | -0.056 |
| % Growth | 98.3% | -26.2% | -18.4% | – |
| Operating Cash Flow | -€4 | -€6 | -€7 | -€9 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€4 | -€6 | -€7 | -€10 |